Wernau Asset Management’s Pfizer PFE Stock Holding History

Wernau Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,500	Closed	-$311K	–	51
2025 Q4	$311K	Sell	12,500 -22,500	-64%	-$567K	0.17%	39
2025 Q3	$892K	Buy	35,000 +15,000	+75%	+$370K	0.61%	24
2025 Q2	$485K	Buy	20,000 +10,000	+100%	+$233K	0.34%	31
2025 Q1	$253K	Buy	10,000 +5,000	+100%	+$131K	0.2%	45
2024 Q4	$133K	Buy	+5,000	New	+$136K	0.1%	50

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wernau Asset Management's PFE Position: Q1 2026 in Review

Wernau Asset Management increased its Pfizer (PFE) stake by 0.13% in Q1 2026, buying an estimated $3.97K and bringing the position to 114,031 shares worth $3.2M. The position accounts for 2.23% of the portfolio, ranked #9.

Wernau Asset Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.2M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Wernau Asset Management held 114,031 shares of Pfizer worth $3.2M as of Q1 2026.
Wernau Asset Management bought 149 Pfizer shares in Q1 2026, an estimated $3.97K.
Pfizer made up 2.23% of Wernau Asset Management's portfolio in Q1 2026, its #9 holding.
Wernau Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
Wernau Asset Management's Pfizer position peaked at $4.2M in Q1 2025.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wernau Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.